216 related articles for article (PubMed ID: 33802342)
1. Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease.
Zhang JQJ; Saravanabavan S; Rangan GK
Cells; 2021 Mar; 10(3):. PubMed ID: 33802342
[TBL] [Abstract][Full Text] [Related]
2. Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney Disease.
Saravanabavan S; Rangan GK
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293397
[TBL] [Abstract][Full Text] [Related]
3. Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease.
Zhang JQJ; Saravanabavan S; Chandra AN; Munt A; Wong ATY; Harris PC; Harris DCH; McKenzie P; Wang Y; Rangan GK
Am J Pathol; 2021 May; 191(5):902-920. PubMed ID: 33549515
[TBL] [Abstract][Full Text] [Related]
4. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
Jamadar A; Suma SM; Mathew S; Fields TA; Wallace DP; Calvet JP; Rao R
Cell Death Dis; 2021 Oct; 12(10):947. PubMed ID: 34650051
[TBL] [Abstract][Full Text] [Related]
5. Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
Trant J; Sanchez G; McDermott JP; Blanco G
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F857-F869. PubMed ID: 37823195
[TBL] [Abstract][Full Text] [Related]
6. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
7. The effect of trehalose on autophagy-related proteins and cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease.
Atwood DJ; Brown CN; Holditch SJ; Pokhrel D; Thorburn A; Hopp K; Edelstein CL
Cell Signal; 2020 Nov; 75():109760. PubMed ID: 32866627
[TBL] [Abstract][Full Text] [Related]
8. Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease.
Arkhipov SN; Potter DL; Sultanova RF; Ilatovskaya DV; Harris PC; Pavlov TS
Physiol Rep; 2023 Apr; 11(7):e15652. PubMed ID: 37024297
[TBL] [Abstract][Full Text] [Related]
9. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
Dwivedi N; Jamadar A; Mathew S; Fields TA; Rao R
Kidney Int; 2023 Jan; 103(1):144-155. PubMed ID: 36273656
[TBL] [Abstract][Full Text] [Related]
10. CD8
Kleczko EK; Marsh KH; Tyler LC; Furgeson SB; Bullock BL; Altmann CJ; Miyazaki M; Gitomer BY; Harris PC; Weiser-Evans MCM; Chonchol MB; Clambey ET; Nemenoff RA; Hopp K
Kidney Int; 2018 Dec; 94(6):1127-1140. PubMed ID: 30249452
[TBL] [Abstract][Full Text] [Related]
11. Role of DNA-Dependent Protein Kinase in Mediating Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.
Chandra AN; Saravanabavan S; Rangan GK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638853
[TBL] [Abstract][Full Text] [Related]
12. The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1
Arroyo J; Escobar-Zarate D; Wells HH; Constans MM; Thao K; Smith JM; Sieben CJ; Martell MR; Kline TL; Irazabal MV; Torres VE; Hopp K; Harris PC
Kidney Int; 2021 Jun; 99(6):1392-1407. PubMed ID: 33705824
[TBL] [Abstract][Full Text] [Related]
13. Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease.
Zhang JQJ; Saravanabavan S; Cheng KM; Raghubanshi A; Chandra AN; Munt A; Rayner B; Zhang Y; Chau K; Wong ATY; Rangan GK
PLoS One; 2021; 16(4):e0248400. PubMed ID: 33886581
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
[TBL] [Abstract][Full Text] [Related]
15. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
16. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
[TBL] [Abstract][Full Text] [Related]
17. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
Cassini MF; Kakade VR; Kurtz E; Sulkowski P; Glazer P; Torres R; Somlo S; Cantley LG
J Am Soc Nephrol; 2018 Oct; 29(10):2471-2481. PubMed ID: 30209078
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
[TBL] [Abstract][Full Text] [Related]
19. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA
FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581
[TBL] [Abstract][Full Text] [Related]
20. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
